Atlas Trials

InnaVirVax

3 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch InnaVirVax

RecordFirmDate
Open-label, Phase I/IIa Study of VAC-3S in HIV-1 Patients Who Showed an Immune Response to VAC-3S During IVVAC-3S/P1 (NCT02390466)InnaVirVax2015-04-01
Assessment of VAC-3S Therapeutic Properties When Combined With Standard ART in the Course of HIV-1 Infection (NCT02041247)InnaVirVax2014-01-01
Phase I/IIa Dose-escalation Clinical Study of VAC-3S (NCT01549119)InnaVirVax2012-02-01

Track InnaVirVax automatically

Every clearance here is in the API, with alerts when new ones post.